November 2018 Vol 9, NO 11
Mark B. Dignan, PhD, MPH, Sharon Dwyer, MS, Elizabeth A Rohan, PhD, MSW, HON-OPN-CG, Dana E. White, MPA, Georgina Castro, MPH, MID, Reda Wilson, MPH, Eric Stockton, BA
Appalachia ranges from southern New York to Mississippi and includes areas with pronounced health disparities, poverty, and elevated rates of cancer and other chronic diseases.
With clinic space becoming a premium at the University of Arizona Cancer Center (UACC), oncology nurse navigators (ONNs) sought an alternative method to connect with all newly diagnosed patients for a time period that was sufficient to introduce the navigation process and conduct a barrier assessment.
Kristin Hand, MSN, RN, OCN, Jillian Burns, BSN, RN, Jennifer Gianguilio, BSN, RN, OCN, Teresa Smink, MSN, RN, OCN, Mary Pat Lynch, MSN, RN, AOCN
The oncology nurse navigator (ONN) team at our academically affiliated community cancer center offers comprehensive navigation across treatment modalities from prediagnosis through survivorship care for patients with a variety of malignancies.
According to the Institute of Medicine report, evidence demonstrates the need for patient education due to the complexity of cancer care.
Breast cancer is the number one diagnosed cancer in Nigeria. Sadly, 75% of the breast cancer diagnoses in Nigeria are discovered in the latter stages of the cancer—stage III and stage IV.
Teresa Smink, MSN, RN, OCN, Debra DeMille, MS, RD, CSO, Tiffany Hogan, MA, CCC-SLP, Christine Huntzinger, DPT, CCCE, CCI, Brianna Morgan, MSN, CRNP, ACHPN, Meredith Pauly, MA, CCC-SLP, Mary Pat Lynch, MSN, RN, AOCN
People living with head and neck cancer incur high risk for symptom clusters involving a cascade of dysphagia, nutrition risk, and deconditioning, followed by often irremediable functional decline.
VCU Health identified a need in the unique and acute population of patients who have leukemia and lymphoma. The leukemia and lymphoma nurse navigator (LLNN) position was created to help close the gaps in care of this population. The role has developed and changed over the years to meet the specific needs of the patients and institution.
Nicole Houston, BSN, RN, CCRP, Irene Ekwede, MSN, BSN, RN, Stephanie Morrissey, RN, BSN, Brittany Bowes, RN, BSN, Eleni Rokakis, RN, BSN, Ruth Phillips, RN, BSN, MS, OCN, Ellie Strock, ANP-BC, FAANP, CDE, Christin Whalen, RN, BSN, OCN
Cediranib-olaparib in combination has been shown to cause rapidly escalating hypertension and severe diarrhea in patients treated for ovarian cancer.
Claire Saxton, Maria B. Gonzalo, MS, Heather R. Hollen, MS, Peggy Rios, PhD, Alexandra K. Zaleta, PhD
Less than 8% of cancer clinical trial enrollees are Latino/Hispanic, although they comprise 17% of the US population.
Evidence suggests that cancer survivors who participate in support groups are less depressed and anxious, have better social well-being, and are more knowledgeable about their disease process.
© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512